{"id":4893,"date":"2026-03-04T13:56:52","date_gmt":"2026-03-04T12:56:52","guid":{"rendered":"https:\/\/www.access2meds.eu\/?p=4893"},"modified":"2026-03-04T13:57:05","modified_gmt":"2026-03-04T12:57:05","slug":"new-ascertain-position-paper-on-pricing-innovative-health-technologies","status":"publish","type":"post","link":"https:\/\/www.access2meds.eu\/hr\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/","title":{"rendered":"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies"},"content":{"rendered":"\n<p>The paper presents insights from two scoping literature reviews examining price determinants, pricing policies, and definitions of \u201cfair\u201d pricing for health technologies. The findings highlight important evidence gaps regarding how pricing decisions are made, which determinants stakeholders consider most relevant, and how affordability and innovation incentives can be balanced.<\/p>\n\n\n\n<p>Based on this evidence, the paper outlines recommendations for improving pricing approaches and strengthening the evidence base for access-oriented pricing models. It also explains how ASCERTAIN is translating research findings and stakeholder perspectives into the development of an access-based pricing model that integrates both cost- and value-based determinants.<\/p>\n\n\n\n<p>The work was developed within ASCERTAIN Work Package 4 and led by Gesundheit \u00d6sterreich GmbH, with contributions from partners across the consortium.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.access2meds.eu\/ASCERTAIN_position_paper_wp4.pdf\">Read the full position paper here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ASCERTAIN has published a new position paper summarising key findings and recommendations from Work Package 4 on pricing innovative health technologies.<\/p>\n","protected":false},"author":5,"featured_media":1450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[21,14,22,23,20],"class_list":["post-4893","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","tag-health-technologies","tag-healthcare","tag-hta","tag-iht","tag-innovative-health-technologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>New ASCERTAIN Position Paper on Pricing Innovative Health Technologies - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"ASCERTAIN has published a new position paper summarising key findings and recommendations from Work Package 4 on pricing innovative health technologies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies\" \/>\n<meta property=\"og:description\" content=\"ASCERTAIN has published a new position paper summarising key findings and recommendations from Work Package 4 on pricing innovative health technologies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-04T12:56:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-04T12:57:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2005\" \/>\n\t<meta property=\"og:image:height\" content=\"1254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lena Jessen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lena Jessen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuta\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/\"},\"author\":{\"name\":\"Lena Jessen\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\"},\"headline\":\"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies\",\"datePublished\":\"2026-03-04T12:56:52+00:00\",\"dateModified\":\"2026-03-04T12:57:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/\"},\"wordCount\":133,\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"keywords\":[\"health technologies\",\"healthcare\",\"HTA\",\"iht\",\"innovative health technologies\"],\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"hr\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/\",\"name\":\"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"datePublished\":\"2026-03-04T12:56:52+00:00\",\"dateModified\":\"2026-03-04T12:57:05+00:00\",\"description\":\"ASCERTAIN has published a new position paper summarising key findings and recommendations from Work Package 4 on pricing innovative health technologies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"width\":2005,\"height\":1254},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\",\"name\":\"Lena Jessen\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies - ASCERTAIN","description":"ASCERTAIN has published a new position paper summarising key findings and recommendations from Work Package 4 on pricing innovative health technologies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/","og_locale":"hr_HR","og_type":"article","og_title":"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies","og_description":"ASCERTAIN has published a new position paper summarising key findings and recommendations from Work Package 4 on pricing innovative health technologies.","og_url":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/","og_site_name":"ASCERTAIN","article_published_time":"2026-03-04T12:56:52+00:00","article_modified_time":"2026-03-04T12:57:05+00:00","og_image":[{"width":2005,"height":1254,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","type":"image\/jpeg"}],"author":"Lena Jessen","twitter_card":"summary_large_image","twitter_creator":"@ASCERTAIN_EU","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Napisao\/la":"Lena Jessen","Procijenjeno vrijeme \u010ditanja":"1 minuta"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/#article","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/"},"author":{"name":"Lena Jessen","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391"},"headline":"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies","datePublished":"2026-03-04T12:56:52+00:00","dateModified":"2026-03-04T12:57:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/"},"wordCount":133,"publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"image":{"@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","keywords":["health technologies","healthcare","HTA","iht","innovative health technologies"],"articleSection":["Allgemein"],"inLanguage":"hr"},{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/","url":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/","name":"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","datePublished":"2026-03-04T12:56:52+00:00","dateModified":"2026-03-04T12:57:05+00:00","description":"ASCERTAIN has published a new position paper summarising key findings and recommendations from Work Package 4 on pricing innovative health technologies.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","width":2005,"height":1254},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/new-ascertain-position-paper-on-pricing-innovative-health-technologies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/"},{"@type":"ListItem","position":2,"name":"New ASCERTAIN Position Paper on Pricing Innovative Health Technologies"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]},{"@type":"Person","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391","name":"Lena Jessen"}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/4893","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/comments?post=4893"}],"version-history":[{"count":1,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/4893\/revisions"}],"predecessor-version":[{"id":4894,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/4893\/revisions\/4894"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media\/1450"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media?parent=4893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/categories?post=4893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/tags?post=4893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}